StemCell Institute Inc. (7096.T)

JPY 1286.0

(-7.28%)

Annual Income Statements

(In JPY)
Breakdown 2024 2023 2022 2021 2020
Revenue 2.48 Billion 2.09 Billion 1.78 Billion 1.4 Billion 1.67 Billion
Cost of Revenue 905.31 Million 755.45 Million 670.68 Million 485.3 Million 543 Million
Gross Profit 1.57 Billion 1.33 Billion 1.11 Billion 924.2 Million 1.13 Billion
Operating Expenses 1.16 Billion 1.03 Billion 884.3 Million 837.32 Million 751 Million
Selling, General and Administrative Expenses 1.13 Billion 1.02 Billion 875 Million 830 Million 750 Million
Research and Development Expenses 11.42 Million 9 Million 9 Million 8 Million 3 Million
Other Expenses - 935 Thousand -9.28 Million 5.43 Million -
Cost and Expenses 2.06 Billion 1.79 Billion 1.55 Billion 1.32 Billion 1.29 Billion
Operating Income 413.75 Million 297.56 Million 226.95 Million 86.87 Million 383 Million
Interest Expense - - 27 Thousand - -
Income Tax Expense 130.34 Million 80.92 Million 78.82 Million 29.07 Million 105 Million
Earnings before Tax 441.32 Million 278.95 Million 212.55 Million 91.44 Million 382 Million
Net Income 310.98 Million 198.03 Million 133.72 Million 62.37 Million 277 Million
Earnings Per Share Basic 30.25 19.33 13.20 6.41 28.46
Earnings Per Share Diluted 30.25 19.33 13.20 6.41 27.03
Weighted Average Shares Outstanding 10.24 Million 10.24 Million 10.12 Million 9.73 Million 9.73 Million
Weighted Average Shares Outstanding (Diluted) 10.24 Million 10.24 Million 10.12 Million 9.73 Million 10.24 Million
Gross Margin 0.64 0.64 0.62 0.66 0.68
EBIT Margin 0.22 0.20 0.17 0.09 -0.00
Profit Margin 0.13 0.09 0.08 0.04 0.17
EBITDA 534.35 Million 383.88 Million 309.46 Million 119.66 Million -1 Million
Earnings Before Tax Margin 0.17 0.14 0.13 0.06 0.23

Income Statement Charts